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Human high- and low-M, kininogens were shown to be potent inhibitors of cysteine proteinases uch as 
cathepsin L and papain (K,= 1748 PM). A strong immunological cross-reaction between the kininogens 
and low-M, a-cysteine proteinase inhibitor from human plasma was found. Comparison of partial amino 
acid sequences from high- and low-M, kininogen and low-M, a-cysteine proteinase inhibitor demonstrated 
sequence identity for all segments analyzed. These findings suggest hat the kininogens and the oc-cysteine 
proteinase inhibitors from human plasma are identical proteins. 
Kininogen Kalfikrein-kinin system cc-Cysteine proteinase inhibitor 
Human plasma protein 
Cysteine proteinase 
I. INTRODUCTION chain portions preformed at the C-terminus [1,2]. 
Two types of kininogens, a high- and a low-M, 
form, are present in human plasma and secretions 
[ 1,2]. The kininogens are the large precursor 
molecules of the vasoactive kinins involved in 
blood pressure regulation [2]. Beyond its role as a 
kinin carrier, high-MF kininogen in a complexed 
form with prokallikrein serves as an assembly fac- 
tor in the intrinsic clotting system [l]. Inhibitory 
functions of the kininogens have not yet been 
recognized. 
Mammalian kininogens are single-chain glyco- 
proteins [l]. They share the heavy chains pre- 
formed at the N-terminus and the consecutive kinin 
segments, but differ considerably in their light 
Abbreviation: CXCPI, cysteine proteinase inhibitor from 
the a-fraction of human plasma 
Cysteine proteinase inhibitors are found in 
human body fluids and tissues [3,4]. Two major 
plasma forms have been identified, commonly 
referred to as low- ((~2) and high-M, (CYI) cysteine 
proteinase inhibitor (cuCPI) [S]. They inhibit thiol 
proteinases with high affinity and specificity [4]. 
Functions apart from the inhibitory capacity of the 
c&PIs have not yet been reported. 
Here, we present evidence from immunological 
cross-reactivity, kinin releasability, inhibitory ac- 
tivity, and amino acid sequence identity, that 
kininogens and CVCPIS from human plasma are 
identical sets of proteins. 
2. MATERIALS AND METHODS 
Kininogens were isolated from human plasma by 
ion-exchange chromatography on DEAE- and 
3fO 
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CM-Sephadex followed by immunoaffinity 
chromatography on immobilized anti-kininogen 
IgGs [2&j. Tryptic cleavage of human kininogens, 
isolation and sequence analysis of the resultant 
fragments was as described in [7]. Antisera against 
the two kininogens were raised in sheep following 
conventional immunization schemes. Double im- 
munodiffusion tests were performed according to 
Ouchterlony [8]. 
Low&& &PI was purified from human plasma 
by affinity chromatography on CM-papain- 
Sepharose and gel filtration on Sephacryl S-200 (in 
preparation). Smaller fragments were separated 
from the virgin molecule by gel chromatography 
on Sephacryl S-200 before and after oxidative 
cleavage of the disulfide bonds. Amino acid se- 
quence analysis of the isolated low-M, &PI 
fragments was by automated solid-phase Edman 
degradation [9]. 
The purity of the resultant proteins was assessed 
by analytical SDS electrophoresis [lo]. For 
Western blotting [l l] and immunoprinting, a ‘251- 
labelled monoclonal antibody (from mouse) 
directed against he heavy chain of human high-M, 
kininogen was used [12]. Kinin was released from 
the proteins by tissue kaliikrein from porcine pan- 
creas and quantitated by radioimmunoassay [ 131. 
Inhibition constants were determined essentially as 
described in [4]. Papain was from Sigma, and 
cathepsin L was isolated from human spleen (in 
preparation). 
3. RESULTS 
To test for the immunological cross-reactivity of 
kininogens and low-M, (rCP1, we applied the dou- 
ble immunodiffusion test (fig. 1). High-M, 
kininogen, low-M, &PI and low-M, kininogen 
were delivered to the upper wells, and sheep an- 
tiserum against high- (fig.lA) and low-M, 
kininogen (fig.lB) to the bottom wells. Applica- 
tion of the anti-low-Mr kininogen immune serum 
yielded a pattern of fused precipitin lines in- 
dicating that low-M, &PI and the two kininogens 
share antigenic sites recognized by the anti-low-Mr 
kininogen-directed antibodies. The antiserum 
against high-M, kininogen formed lines of partial 
identity with low-M, c&PI and high% kininogen 
(fig. 1 A, arrowhead) indicating that the anti-high- 
it& kininogen-directed IgGs recognize both 
I I 
Fig. 1. Double immunodiffusion test [8] of high-&& 
kininogen (l), low-M, &PI (2), and low-M, kininogen 
(3) with antiserum against high-Mr kininogen (a) and 
low-M, kininogen (b). 
epitopes common to high-M, kininogen and low- 
M, ryCP1 as well as antigenic sites unique for high- 
I+& kininogen. Immunoprinting revealed that a 
monoclonal antibody directed against the heavy 
chain portion of the human high-M* kininogen also 
recognized human low-&fX &PI (not shown). 
In view of the extensive immunolo~~al cross- 
reactivity of low-M, &PI and the human 
kininogens, we tested the kininogens for their in- 
hibitory activity against cysteine proteinases. The 
thiol proteinases cathepsin L (from human spleen) 
and papain (from Papaya latex) were used. Table 
1 lists the inhibition constants (Ki ranging from 17 
to 48 PM) for the two enzymes and the human 
kininogens thus classifying the kininogens as po- 
tent inhibitors of cysteine proteinases. For com- 
parison, the inhibition constants for human low- 
&& crCP1 [4] are included in the table. Both sets of 
Ki values are in the same order of magnitude. 
Hence, these data stress the similarity, if not iden- 
tity of the &PIs and the kininogens. 
To further evaluate this possibility, we have 
probed for releasable kinin from low-M, &PI. 
Table 1 
Inhibition constants Ki (PM) of low- and high-ill, 
kininogen with papain and cathepsin L 
Cysteine 
proteinase 
Cathepsin L
Papain 
CPI 
62 
34 
LOW-M, High-M, 
kininogen kininogen 
48 nd 
17 20 
For comparison, the data for low-M, cvCP1 are included 
141. nd, not determined 
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270 280 290 300 
(al DIPTNSPELEETLTHTITKLNAENXATFYFKI 
(b) KICVGCPRDIPTNSPELEETLTHTITKLNAENNATFYFKI 
tc) RLCAGCPKPIPVDSPDLEEPLSHSIAKLNAEHDGAFYFKI 
310 320 
(a) DNVKKARVQVVAGKRYFIDFVARET 
(b) D(N,V,K,K,A)R V Q V V A G X R Y F I D F V A R E T T C S K 
(c) DTVKKATVQVVAGLKYSIVFIARETTCSK 
Fig.2. Alignment of the partial amino acid sequences from (a) the N-terminal portion of the 15 kDa fragment from 
human low-M, &PI with the C-terminal parts of the heavy chains from human [7] and bovine [ 151 high-Mr kininogens. 
Numbers indicate the positions of the residues in the cDNA-derived amino acid sequence of bovine high-MC kininogen 
1151. 
The inhibitor was subjected to limited proteolysis 
by tissue kallikrein, and liberated Lys-bradykinin 
was quantitated by radioimmunoassay. A small, 
though distinct quantity of lysyl-bradykinin 
amounting to some 4% of the theoretically 
releasable kinin was present in our low-M, &PI 
preparation. This suggests that major part of the 
low-M, &PI had already undergone proteolytic 
cleavage, possibly during its isolation from human 
plasma. These results were corroborated by find- 
ings from SDS-gel electrophoresis indicating that 
the predominant part of the low-M, &PI was pre- 
sent in a two-chain form, with a heavy chain 
(62 kDa) connected to a light chain (5 kDa) by 
disulfide-bridging (not shown). In addition, a 
minor fragment of 15 kDa was found. 
Amino acid sequence analysis of human 
kininogens was done with tryptic fragments de- 
rived from the heavy chain portion of high-M, 
kininogen (in preparation) and the light chain of 
low-M, kininogen [7]. Partial amino acid sequence 
determination of low-M, &PI was carried out 
with smaller fragments of apparent molecular 
mass 15 and 5 kDa prepared from the purified in- 
hibitor (in preparation). Comparison of the 
resulting sequence data indicated that the fragment 
of Mr 15 000 exhibited total sequence identity to the 
known sequence portions of the high-M, kininogen 
heavy chain (fig.2). Similarly, the alignment of the 
sequences of the 5 kDa fragment of low-M, &PI 
and the light chain of low-M, kininogen 
demonstrated total identity of the analyzed protein 
portions (fig.3). 
4. DISCUSSION 
Our results indicate that kininogens are strong 
inhibitors of cysteine proteinases; probably they 
are the most abundant inhibitors of thiol pro- 
teinases in plasma (total kininogen concentration 
210 mg/l) and urine (l-6 mg/l) [14]. Comparison 
of the sequences of several low-M, cysteine pro- 
teinase inhibitors of the cystatin- and stefin-type 
reveals a well conserved stretch of amino acids 
located in the center portion of the inhibitor 
molecules (fig.4). This segment has been suggested 
390 400 410 420 430 
(a) IGEIKEETTSHLRSCEYKGRPPKAGAEPASERGVS 
(b) SSRIGEIKEETTSHLRSCEYKGRPPKAGAEPASERGVS 
(c) SVQVMKTEGSTTTHVKSCEYKGRPQEAGAEPAPQGEVSLPAESPQLAR 
Fig.3. Alignment of the partial amino acid sequences from (a) the 5 kDa fragment of the human low-M, &PI with 
the light chains from (b) human [7] and (c) bovine [17] low-M, kininogens. Numbers indicate the positions of the 
residues in the cDNA-derived amino acid sequence of bovine low-M, kininogen [16]. 
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to contain the reactive site of the inhibitors [3]. In- 
terestingly, a highly homologous segment is also 
present in the heavy chain of the human 
kininogens some 110 amino acids upstream from 
the kinin segment (fig.4). This suggests that the 
reactive site mediating the inhibitory function of 
the kininogens might reside in their heavy chain. 
At present we do not know the precise effect of 
kinin release on the inhibitory function of the 
kininogens. However, preliminary evidence sug- 
gests that kinin-free low-M, kininogen still inhibits 
cysteine proteinases. Our findings support the 
emerging idea [2] of the kininogens being multi- 
functional, multi-domain molecules which serve 
such different functions such as kinin delivery, sur- 
face attachment, kallikrein binding, and inhibition 
of cysteine proteinases. 
The results from the partial amino acid sequenc- 
ing of human kininogens and low-M, &PI strong- 
ly suggest - though they do not entirely prove - 
that low-M, kininogen and low-M, &PI on one 
hand and high-Mr kininogen and high-M, &PI on 
the other hand are identical proteins. Additional 
evidence for this fact comes from cDNA sequenc- 
ing [18] demonstrating that human low-M, 
kininogen and low-M, &PI are identical on the 
cDNA level. 
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(e) QPPTRLCAGCPKPIPVDSPD--LEEPLSHSIAKLNAEHDG 
260 270 280 290 
50 60 70 80 
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(b) human stefin [9], and (c) human cystatin [3] with (d) partial sequences of human high-Mr kininogen and (e) bovine 
low-M, kininogen [16]. Allowance for gaps (indicated by dashes) has been made to improve the alignment. Residues 
identical in human kininogen and at least one of the inhibitors are boxed. 
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